InMode
INMD
14.00
-0.01
-0.07%
InMode
US · INMD
#3410 by market cap
Listed 2019
14.00
-0.01
-0.07%
Live - 5344 symbols - heartbeat 221s ago
· 2026-10-08 09:57
Pre-market
13.99
-0.14%
After-hours
13.85
-1.12%
- Market cap
- 805.62M
- P/E (TTM)i
- 11.57
- P/Bi
- 1.28
- EPSi
- 1.43
- Div yieldi
- 0.00%
- 52W posi
- 32%
Reader sentiment
Are you bullish or bearish on INMD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 9.41, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -6.16% YoY
Margins
- Gross margin
- 78.54%
- Operating margin
- 23.05%
- Net margin
- 25.33%
Key ratios & quality
- Altman Z-Scorei
- 9.41
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 100.16M | 156.36M | 206.11M | 357.57M | 454.27M | 492.05M | 394.82M | 370.50M |
| Gross profit | 85.11M | 136.12M | 175.26M | 303.97M | 380.79M | 411.34M | 317.07M | 290.97M |
| Selling & admin expenses | 49.44M | 70.81M | 92.95M | 127.76M | 170.51M | 202.27M | 191.40M | 192.26M |
| Research & development | 4.18M | 5.70M | 9.47M | 9.53M | 12.43M | 13.41M | 13.14M | 13.32M |
| Operating profit | 31.49M | 59.62M | 72.84M | 167.48M | 197.85M | 195.66M | 112.53M | 85.39M |
| Pretax profit | 23.63M | 62.04M | 76.13M | 168.00M | 201.47M | 217.27M | 143.47M | 110.33M |
| Tax | 1.26M | 883.00K | 1.11M | 2.93M | 39.95M | 19.35M | -37.81M | 16.50M |
| Net profit | 22.37M | 61.16M | 75.03M | 165.07M | 161.52M | 197.92M | 181.28M | 93.83M |
| Basic EPS | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 1 |
| Diluted EPS | 0.35 | 0.80 | 0.89 | 1.92 | 1.89 | 2.30 | 2.25 | 1.43 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 77.87M | 95.60M | 93.17M | 103.85M | 82.02M | 95.59M |
| Gross profit | 60.91M | 76.45M | 72.31M | 81.30M | 61.55M | 71.52M |
| Selling & admin expenses | 42.40M | 50.20M | 47.87M | 51.80M | 47.95M | 55.60M |
| Research & development | 2.90M | 3.37M | 3.54M | 3.51M | 3.54M | 3.66M |
| Operating profit | 15.62M | 22.88M | 20.90M | 25.99M | 10.06M | 12.26M |
| Pretax profit | 22.48M | 30.94M | 25.62M | 31.29M | 14.35M | 19.69M |
| Tax | 4.28M | 4.20M | 3.76M | 4.27M | 2.79M | 2.63M |
| Net profit | 18.20M | 26.74M | 21.86M | 27.03M | 11.56M | 17.06M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.26 | 0.42 | 0.34 | 0.42 | 0.18 | 0.29 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 77.76M | 213.21M | 289.59M | 470.11M | 629.37M | 845.33M | 714.45M | 698.62M |
| Cash & ST investments | 61.30M | 193.36M | 260.53M | 415.91M | 547.38M | 741.61M | 596.47M | 555.33M |
| Inventory | 6.96M | 9.41M | 14.98M | 21.03M | 39.90M | 45.10M | 59.55M | 74.05M |
| Total assets | 81.06M | 218.39M | 295.76M | 478.54M | 644.41M | 863.29M | 785.67M | 766.43M |
| Total current liabilities | 29.43M | 32.49M | 35.03M | 51.85M | 82.02M | 64.14M | 69.85M | 70.74M |
| Short-term debt | -- | -- | 880.00K | 1.21M | 1.45M | 2.40M | 2.51M | 3.22M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 36,380,000.00 | 38,582,000.00 | 40,286,000.00 | 62,739,000.00 | 89,791,000.00 | 75,914,000.00 | 81,854,000.00 | 83,231,000.00 |
| Total equity | 44.68M | 179.80M | 255.48M | 415.80M | 554.62M | 787.37M | 703.81M | 683.20M |
| Retained earnings | 32.97M | 93.99M | 169.02M | 333.99M | 495.51M | 693.43M | 874.70M | 968.53M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 634.64M | 638.78M | 666.29M | 698.62M | 680.78M | 650.00M |
| Cash & ST investments | 512.93M | 510.68M | 532.31M | 555.33M | 537.16M | 501.12M |
| Inventory | 63.78M | 68.11M | 71.40M | 74.05M | 71.41M | 71.66M |
| Total assets | 704.74M | 708.35M | 734.61M | 766.43M | 750.84M | 720.33M |
| Total current liabilities | 72.66M | 66.53M | 68.33M | 70.74M | 77.35M | 79.44M |
| Short-term debt | -- | -- | -- | 3.22M | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 85,307,000.00 | 79,911,000.00 | 81,220,000.00 | 83,231,000.00 | 89,584,000.00 | 91,197,000.00 |
| Total equity | 619.43M | 628.44M | 653.39M | 683.20M | 661.25M | 629.13M |
| Retained earnings | -- | -- | -- | 968.53M | -- | -- |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 36.89M | 62.21M | 79.23M | 174.89M | 181.58M | 176.83M | 132.66M | 85.26M |
| Depreciation & amortization | 184.00K | 302.00K | 416.00K | 517.00K | 680.00K | 623.00K | 728.00K | 695.00K |
| Free cash flow | 36.51M | 61.51M | 78.76M | 173.95M | 180.00M | 176.12M | 132.00M | 84.29M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 69.78M | -17.22M | -35.37M | -42.64M | 0 | -285.39M | -127.44M |
| Ending cash balance | 24.72M | 44.73M | 68.94M | 68.14M | 97.54M | 144.41M | 155.33M | 302.54M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 14.04M | 24.07M | 24.47M | 22.67M | 15.39M | 21.05M |
| Depreciation & amortization | 174.00K | 191.00K | 156.00K | 174.00K | 175.00K | 179.00K |
| Free cash flow | 13.96M | 23.85M | 24.33M | 22.14M | 15.21M | 20.84M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -99.96M | -27.48M | 0 | 0 | -31.24M | -56.51M |
| Ending cash balance | 145.95M | 216.24M | 252.44M | 302.54M | 394.30M | 396.17M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 71.34 | 55.76 | 34.90 | 49.26 | 33.29 | 29.50 | 24.31 | 13.53 |
| ROA %i | 37.13 | 40.84 | 29.19 | 42.61 | 28.77 | 26.25 | 21.99 | 12.09 |
| ROIC %i | 70.93 | 53.22 | 33.30 | 48.67 | 32.38 | 26.29 | 20.80 | 10.39 |
| 5-year avg ROE %i | -- | -- | -- | 51.32 | 48.91 | 40.54 | 34.25 | 29.98 |
| EBIT margin %i | 31.44 | 38.13 | 35.34 | 46.84 | 43.55 | 39.76 | 28.50 | 23.05 |
| FCF / sales %i | 36.45 | 39.34 | 38.21 | 48.65 | 39.62 | 35.79 | 33.43 | 22.75 |
| Current ratioi | 2.64 | 6.56 | 8.27 | 9.07 | 7.67 | 13.18 | 10.23 | 9.88 |
| Quick ratioi | 2.41 | 6.27 | 7.77 | 8.50 | 7.02 | 12.24 | 9.13 | 8.55 |
| Debt / assetsi | 0.00 | 0.34 | 0.42 | 0.94 | 0.77 | 1.04 | 1.00 | 1.07 |
| LT debt / equityi | -- | 0.42 | 0.14 | 0.80 | 0.63 | 0.84 | 0.75 | 0.73 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | 56.81 | 52.83 | 42.69 | 33.65 | 3.36 | -6.57 |
| Net income CAGR (3Y) %i | -- | -- | 104.14 | 94.64 | 38.24 | 38.17 | 3.19 | -16.56 |
| FCF CAGR (3Y) %i | -- | -- | 76.11 | 68.28 | 43.03 | 30.77 | -8.79 | -22.35 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 24.50 | 25.91 | 21.52 | 13.53 | 13.62 | 12.33 |
| ROA %i | 22.02 | 22.79 | 19.19 | 12.09 | 11.98 | 10.85 |
| ROIC %i | 21.05 | 25.69 | 21.35 | 10.39 | 10.55 | 12.23 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 28.05 | 28.54 | 23.94 | 23.05 | 21.31 | 18.47 |
| FCF / sales %i | 31.08 | 25.90 | 25.89 | 22.75 | 22.83 | 22.03 |
| Current ratioi | 8.73 | 9.60 | 9.75 | 9.88 | 8.80 | 8.18 |
| Quick ratioi | 7.86 | 8.58 | 8.71 | 8.55 | 7.88 | 7.28 |
| Debt / assetsi | 0.79 | 0.86 | 0.76 | 1.07 | 0.64 | 0.62 |
| LT debt / equityi | 0.90 | 0.97 | 0.86 | 0.73 | 0.73 | 0.71 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Minimal-Invasive is the largest reported line at 77.00% of revenue, across 3 reported segments.
- The next-largest line, Non-Invasive, is a distant second at 22.00% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Minimal-Invasive77.00%
Non-Invasive22.00%
Hands-Free1.00%
Quote time 2026-10-08 09:57:48 · For reference only, not investment advice and not tailored to your situation.